Lice “Smothering” Agents Should Be Explored, Researchers Assert
This article was originally published in The Tan Sheet
Further research on topical agents that can asphyxiate lice should be conducted to enhance current treatment methods, according to a commentary published in the April issue of the Journal of the American Academy of Dermatology
You may also be interested in...
Summers Laboratories is actively enrolling patients in a Phase III clinical trial for its patented lice asphyxiator product, tentatively named Lice Choker, the company announces April 24. An NDA for sale of the product as an Rx drug will be filed in the fourth quarter of 2006. The product contains "a simple mixture of ingredients currently used in other dermatological medications and cosmetics" and will suffocate lice more successfully than olive oil and petroleum jelly, Summers maintains. According to studies, two 10-minute applications of the product one week apart effectively kill all lice, the company states, with one study showing a 100% effective kill rate. A recent article in the Journal of the American Academy of Dermatology said asphyxiating treatments should be further researched, given the increasing resistance of lice to OTC pyrethroid-based formulas (1"The Tan Sheet" April 17, 2006, p. 13)...
A head lice lotion that suffocates the insects cured 97% of children who used the treatment on the first try, according to a study in the September issue of Pediatrics
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC